Wijkstrom Joakim
- SEC CIK
- 0001785888
In the past year, 1 open-market sale filing worth $254.7K and no purchases.
Current role at each company
- VNDA Vanda Pharmaceuticals Inc.SVP, Chief Marketing Officeras of Mar 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $254.7K
- 1 filing
- Net
- −$254.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wijkstrom Joakim as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Wijkstrom JoakimSVP, Chief Marketing Officer | SSale | −30.8K | $8.27 | −$254.7K | −8.5%333.5K after | |
| Mar 6, 2024 (view filing) | Mar 4-5 | 2 days | Wijkstrom JoakimSVP, Chief Marketing Officer | SSale | −16.7K | $4.30 | −$71.9K | −11.4%129.8K after | 2 lots |
| Aug 23, 2023 (view filing) | Aug 21 | 2 days | Wijkstrom JoakimSVP, Chief Marketing Officer | SSale | −3.72K | $5.84 | −$21.7K | −3.2%113.8K after | |
| Mar 6, 2023 (view filing) | Mar 2-3 | 4 days | Wijkstrom JoakimSVP, Chief Marketing Officer | SSale | −11.8K | $6.26 | −$74.1K | −9.1%117.5K after | 2 lots |
| Aug 23, 2022 (view filing) | Aug 22 | 1 day | Wijkstrom JoakimSVP, Chief Marketing Officer | SSale | −3.60K | $10.27 | −$37.0K | −3.6%96.7K after | |
| Mar 2, 2022 (view filing) | Mar 2 | Same day | Wijkstrom JoakimSVP, Chief Marketing Officer | SSale | −6.97K | $11.19 | −$78.0K | −6.5%100.3K after | |
| Aug 23, 2021 (view filing) | Aug 20 | 3 days | Wijkstrom JoakimSVP, Chief Marketing Officer | SSale | −3.65K | $15.39 | −$56.2K | −4.7%74.6K after |